Clinical Trial Update: A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating safety and efficacy of panitumumab combined with TAS-102 in colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)
• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Takeda | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-24